RICHA SHUKLA to Remission Induction
This is a "connection" page, showing publications RICHA SHUKLA has written about Remission Induction.
Connection Strength
0.056
-
A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn's disease. J Crohns Colitis. 2025 May 08; 19(5).
Score: 0.056
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.